Bioimpedance Analyzers Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2032

Page: 214 | Report Code: LS24052401 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

Bioimpedance analyzers, also known as bioelectrical impedance analyzers (BIA), are noninvasive devices that measure body composition by passing a small electrical current through the body and measuring the voltage. The amount of resistance measured is inversely proportional to the volume of electrolytic fluid in the body. It can calculate total body water, extracellular fluid, lean body mass, fat mass, percent of mass, body cell mass and intercellular water. It provides quick and easy measurement that can be taken within minutes and provides a wide range of body composition metrics, making it a valuable tool in both clinical and fitness settings.

MARKET OVERVIEW

The global market valuation of Bioimpedance Analyzers market was valued at approximately USD 568 million in 2023 and is projected to reach USD 999.1 million in 2032 exhibiting a CAGR of 9.8% during the forecast period of 2024-2032. Bioimpedance Analyzers provides detailed insights of the body’s metrics and helps in informed decision-making for the individuals and healthcare professionals. The market is aligned with healthcare sector, which makes it a sustainable and growing market.


GROWTH DRIVERS

The increasing incidence of obesity and lifestyle diseases like diabetes and cardiovascular conditions drives the demand for accurate body composition analysis. According to World Health Organization (WHO), in 2022, 16% of adults aged 18 and older worldwide were obese, which is more than double the rate from 1990. This includes over 670 million adults and at least 120 million children and adolescents, for a total of over 1 billion people worldwide.

The WHO estimates that by 2025, an additional 167 million people will become less healthy due to obesity or being overweight. The growing awareness of health and fitness in one of a significant driver of the market, as more individuals become more health conscious, the demand for tools like bioimpedance analyzers grows. The total revenue is expected to show an annual growth rate during the forecast of 2022 to 2027 is approximately 9.61%, resulting in a projected market volume of USD 6.7billion by 2027, according to Statista.

According to a new report from the Global Wellness Institute, the wellness industry has grown from $3.4 trillion in 2013, it is expected to grow an additional 57%, to $8.5 trillion by 2027, about twice as large as Germany’s gross domestic product. The rise in geriatric population drives the market towards growth, as the aging population increases the need for regular health monitoring becomes crucial. According to WHO, in 2022, the global geriatric population, or people aged 65 and older, was 771 million, which is almost 10% of the world's population.

This number is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which would double the number of people aged 60 and older. By 2050, the percentage of the global population aged 65 and older is expected to increase to 16%. The ability to track and analyze body composition data over time through integration with digital health platforms drives the market towards growth.

The expansion of fitness industry where gyms and fitness centers offer more comprehensive services, the integration of bioimpedance analyzers into fitness assessments, contributes towards market growth. According to Statista, the health and fitness club market worldwide was estimated to grow at a rate of 7.67 percent annually during the forecast of 2023 and 2030, by 2030, this industry was estimated to be worth approximately USD 169.7 billion.

MARKET SEGMENTATION:

·         By Device Type– Single frequency bioimpedance analyzers, dual-frequency bioimpedance analyzers and multiple-frequency bioimpedance analyzers

·         By Application – Segmental body measurement and whole-body measurement

·         By Modality - Wire and wireless bioimpedance analyzers

·         By End-User- Hospitals & Clinics, Fitness and wellness centers, home user settings and others

·         By Region- North America, Europe, Asia Pacific, The Middle East and Africa, South America

Bioimpedance Analyzers Market Segment By Device Type Segment Review:

Single frequency bioimpedance analyzers utilizes single frequency mainly around 50kHz to measure the impedance of body tissues. It provides basic measurements of the body composition like fat percentage and total body water. It is commonly used in home settings for personal health monitoring due to their simplicity and affordability and in fitness centers for basic fitness. The dual frequency bioimpedance analyzers uses two different frequencies, that is around 5 kHz to 50 kHz to provide more detailed and accurate composition analysis. It offers in improved accuracy over single frequency devices allowing for better differentiation between intracellular and extracellular under water.

The multiple frequency bioimpedance analyzers utilizes multiple frequency ranging from 1kHz to 1MHz to measure impedance across different tissue types and depths in the body. It provides comprehensive and highly accurate body composition analysis, including segmental measurements of arms, legs and trunk. It is commonly used in hospitals and specialized clinics for detailed health assessments. It is employed by professional sports teams and high-end fitness centres for precise monitoring of athlete's body composition.


Bioimpedance Analyzers Market Segment By Application Segment Review:

The segmental body measurement bioimpedance just impedance across different body segments like arms, legs and trunk separately. It provides detailed analysis of body composition and specific areas of the body including muscle mass, fat distribution and water content in each segment. It is used for precise diagnosis and monitoring of health conditions that affect specific body segments like lymphedema, sarcopenia and localized obesity.

The whole-body measurement bioimpedance analyzers measures the overall impedance of the entire body without distinguishing between different segments it provides an overall assessment of the body composition including total body fat percentage, total lean mass and total body water. It is user-friendly, quick and straight forward for general use.

Bioimpedance Analyzers Market Segment By Modality Segment Review:

 The wire bioimpedance analyzers are wired connections to transmit electrical signal and measure body impedance. It involves direct physical connections between the analyzer and electrodes attached to the body. It provides stable and consistent, less susceptible to interference and are commonly used in fitness centers and clinical settings.

The wireless bioimpedance analyzers utilizes wireless connections like Bluetooth or Wi-Fi to transmit signals and collect the impedance data. It involves portable or wearable devices that communicate data to a central system or smartphone applications without the need for physical cables. It is convenient and flexible, allowing for mobile use and integration with digital platforms and ideal for home use, sports and dynamic clinical environments.

Bioimpedance Analyzers Market Segment By End-User Segment Review:

In the hospitals and clinics segment, the medical professionals including doctors, nurses and dieticians uses it for diagnostic purpose and monitoring tool for assessing body composition in the patients. It used to evaluate and monitor patients with conditions like obesity, malnutrition, heart disease, kidney disease and fluid imbalances. It is also used in the management of chronic diseases like diabetes and cardiovascular diseases by regular tracking changes in the body composition. In the fitness and wellness centers it is used by fitness trainer, wellness coaches and gym members to assess and track body composition as a part of fitness and wellness programs.

It commonly utilized for evaluating the starting fitness level of new members and tracking their progress overtime designing and adjusting exercise and nutrition plans based on the detailed composition body composition data. In the home user settings, it is used by individual customers interested in tracking their health and fitness. It provides convenient and regular monitoring of body composition from the comfort of home. It allows the users of keeping track of body fat, muscle mass, and hydration levels regularly and supports weight loss or muscle gain goals with precise data. It also helps in early detection of potential health issues through a regular monitoring.

Bioimpedance Analyzers Market Regional Analysis:

North America is a significant market driven by the factors like the presence of advanced healthcare infrastructure which supports the adoption of advanced diagnostics tools including bioimpedance analyzers. The region’s increase in obesity rate is one the significant driver of the market. According to Harvard Edu, about two-thirds of US adults are overweight or obese, and 36% are obese. As of 2022, all 50 states have an obesity rate of over 20%, and 17 states have an obesity rate of over 35%. Europe is another significant market driven by factors like the presence of robust healthcare infrastructure and rising aging population. Asia Pacific is a rapidly growing market driven by the factors like rapid urbanization and lifestyle changes which leads to higher incidence of obesity and cardiovascular diseases. The Middle East and Africa is a growing market driven by factors like infrastructure development including healthcare infrastructure.  South America is a promising market due to urbanization and increasing obesity rate.


Key Challenges:

The high cost associated with the advanced bioimpedance analyzers may limits the accessibility and affordability on the emerging markets and smaller healthcare units.  The bioimpedance analyzers requires proper training to operate and interpret results accurately and complexity increases with the sophistication of the device. The lack of trained personnel may lead to new user or inaccurate interpretation of data, which may hinder the adoption of the device.  The wireless analyzers that transmit data via Bluetooth or Wi-Fi are suspectable to data breaches, where concerns over patient data privacy and security may hinder the adoption of wireless devices.

Competitive Landscape:

In the highly competitive Bioimpedance Analyzers market, companies are investing heavily in research and development to innovate and improve the product and services. They are also collaborating, forming strategi partnerships, or acquiring other companies to gain access to new market segments, enhance distribution networks, and increase market share. Recent developments includes – Bodystat Ltd. Launched Multiscan 5000, in 2023. InBody Co. announced about supplying InBody 770 analyzer to the US marine cops. Analog Devices launched MAX30009, clinical-grade vital sign measurement for patient assessment, in March 2022. InBody (South Korea) introduced BWA 2.0 body water analyzer to provide users with more detailed insights that demonstrate how variations in body composition and body water can affect well-being, in April 2022.

Global Key Players:

·         Tanita Corporation

·         Seca GmbH & Co. KG

·         Maltron International Ltd.

·         Akern

·         RJL Systems

·         Accuniq (SELVAS Healthcare)

·         InBody Co., Ltd.

·         Bodystat Ltd.

·         Omron Corporation

·         Charder Medical

Attributes

Details

Base Year

2023

Trend Period

2024 – 2032

Forecast Period

2024 – 2032

Pages

215

By Device Type

Single frequency bioimpedance analyzers, dual-frequency bioimpedance analyzers and multiple-frequency bioimpedance analyzers

By Application

Segmental body measurement and whole-body measurement

By Modality

Wire and wireless bioimpedance analyzers

By End-User

Hospitals & Clinics, Fitness and wellness centers, home user settings and others

By region

North America, Europe, Asia Pacific, the Middle East and Africa, and South America

Company Profiles

Tanita Corporation, Seca GmbH & Co. KG, Maltron International Ltd., Akern, RJL Systems, Accuniq (SELVAS Healthcare), InBody Co., Ltd., Bodystat Ltd., Omron Corporation, Charder Medical

Edition

1st edition

Publication

May 2024

Buy Report

  • $1990
  • $2990